ArticleComputational and structural biotechnology journal2025
In-depth analysis of the RNA editing landscape in intracranial aneurysms and its potential role in alternative splicing.
Article in Computational and structural biotechnology journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Long-Read Sequencing Reveals RNA Splicing Complexity in Human Diseases.Computational and structural biotechnology journal · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Intracranial aneurysm (IA) is a focal localized dilation of cerebral arteries and is a life-threatening cerebrovascular disease. Emerging evidences have emphasized the significance of post-transcriptional regulation in diseases, particularly through the two most critical regulatory layers of RNA editing (RE) and alternative splicing (AS). However, the interplay between these mechanisms and their impact on IA pathophysiology remains unclear. This study integrated multi-cohort datasets to establish a comprehensive landscape of RE in IAs. We observed a marked decrease in RNA editing levels during the transition from unruptured to ruptured aneurysms. Further analysis revealed a dual mechanism of AS by RE: direct modulation of AS via edits near splice sites that alter regulatory sequences, and indirect influence through changes in the binding affinity and specificity of RNA-binding proteins (RBPs). By constructing an RES-RBP-AS regulatory network, we identified key nodes potentially involved in IA progression via RE-mediated splicing regulation. These findings not only provide new insights into IA molecular mechanisms, but also lay a theoretical foundation for the developing therapies strategies targeting post-transcriptional regulation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.